Beer-flavored beverages
The beer-tasting beverage formulation, featuring elevated concentrations of 3-methyl-2-butene-1-thiol and 2-acetyltetrahydropyridine compounds, addresses the challenge of achieving richness and flavor balance in low-malt beer-tasting drinks, resulting in a product with enhanced sensory attributes.
JP7655714B2Active Publication Date: 2025-04-02ASAHI BREWERIES LTD
8 Cites 0 Cited by
Patent Information
- Application Number
- JP2020167956
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-10-02
- Publication Date
- 2025-04-02
- Estimated Expiration
- 2040-10-02
AI Technical Summary
Technical Problem
Beer-tasting drinks with low malt content struggle to achieve a balance between richness and flavor, as the concentration of proline is often too low and 3-methyl-2-butene-1-thiol can impart an off-flavor when present in high amounts.
Method used
A beer-tasting beverage is formulated with a concentration of 3-methyl-2-butene-1-thiol at 2.0 ng/l or more and a concentration of 2-acetyltetrahydropyridine compounds, such as 2-acetyl-3,4,5,6-tetrahydropyridine, at 5.0 μg/l or more, along with proline, to enhance richness and balance flavor.
Benefits of technology
The formulation achieves a beer-tasting beverage with excellent flavor balance, enhanced richness, and low malt content, effectively addressing the limitations of existing low-malt beer-tasting drinks.
✦ Generated by Eureka AI based on patent content.
Abstract
To provide a beer-flavored beverage which has a well-balanced flavor and enhanced richness and uses only a small amount of malt.SOLUTION: The present invention discloses a beer-flavored beverage which contains 3-methyl-2-butene-1-thiol and at least one 2-acetyltetrahydropyridine compound selected from the group consisting of 2-acetyl-3,4,5,6-tetrahydropyridine and 2-acetyl-1,4,5,6-tetrahydropyridine, which is a tautomer thereof. The concentration of 3-methyl-2-butene-1-thiol is 2.0 ng / l or more. The concentration of the 2-acetyltetrahydropyridine compound is 5.0 μg / l or more.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art